Showing results (651-660 of 763) with videos related to

Sort By:
Pageof 77
Pediatric Nephrology (Berlin, Germany)|November 26, 2024
C3 glomerulopathy in children: a European longitudinal study evaluating outcomeAndrea Cappoli, Tanja Kersnik-Levart, Valeria Silecchia, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2009
Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritisBart Smeets, Maria Lucia Angelotti, Paola Rizzo, et al.
Kidney International Supplements|January 25, 2019
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney diseaseCarol Pollock, Anna Zuk, Hans-Joachim Anders, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
Pharmacological Research|March 17, 2024
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic reviewMichelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, et al.
JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Pageof 77